Nalaganje...
Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists are often recommended as part of combination therapy for type 2 diabetes when oral medication does not result in sufficient glycemic control. Several GLP-1 receptor agonists are available as weekly injections. These medications vary in th...
Shranjeno v:
| izdano v: | BMC Health Serv Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5702146/ https://ncbi.nlm.nih.gov/pubmed/29178918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-017-2648-7 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|